NIKA PHARMACEUTICALS, INC — SEC Form 4 filings

SEC reporting owner CIK 1145604. 2 Form 4 filings on record with FilingPulse; latest filed 2024-03-19.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2024-03-19 to 2024-03-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NIKA PHARMACEUTICALS, INC (NKPH)President, CEO, CFO, Director, 10% owner21 leg · 11,489,000 sh · $137,8686 legs · 22,550,000 sh · $410,0004

Form 4 filings — NIKA PHARMACEUTICALS, INC

FiledFormIssuerReported transactionsSource
2024-03-194NIKA PHARMACEUTICALS, INC (NKPH)Other (J): 10,000,000 @ $3,000,000 · Purchase (P): 11,489,000 @ $0.01 · Other (J): 333,181,000 @ $0 · Sale (S): 7,000,000 @ $0.02 · Sale (S): 1,250,000 @ $0.02 · Sale (S): 3,000,000 @ $0.04 · +3 moreEDGAR
2024-03-194NIKA PHARMACEUTICALS, INC (NKPH)Other (J): 5,000,000 @ $50,000 · Other (J): 145,000,000 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1145604 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →